Bill Clinton praises the CBD clinical study as “very encouraging”.

The clinical study, conducted by researchers at NYU Langone Health and Baptist Health/Jacksonville Orthopedic Institute, found that an orally absorbed cannabidiol (CBD) pill “safely manages pain after minimally invasive rotator cuff surgery and does not produce the side effects sometimes associated.” with CBD ingestion, such as nausea, anxiety, and liver toxicity.”

The researchers randomly sorted 99 participants at two study sites, NYU Langone and Baptist Health in Jacksonville, “between the ages of 18 and 75 into a placebo group and a group that received orally absorbed CBD” who were “prescribed a low dose of Percocet, instructed.” , wean off the anesthetic as soon as possible and take the placebo/CBD 3 times a day for 14 days after surgery.

“On the first day after surgery, patients receiving CBD experienced an average of 23 percent less pain as measured by the visual analog scale (VAS) pain score compared to patients receiving the placebo, highlighting that CBD is beneficial in patients with moderate pain may have a significant effect,” the researchers write in their analysis. “On both the first and second days after surgery, patients who received CBD reported 22 to 25 percent greater satisfaction with pain control compared to those who received placebo. Further analysis also showed that patients receiving 50mg of CBD reported less pain and greater satisfaction with pain control compared to patients receiving placebo. No major side effects have been reported.”

The results of the study were presented in March at the 2022 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting in Chicago.

On Monday, TR Processing LLC announced that it was serving as the CBD supplier for Orcosa Inc., the maker of Oravexx used for the clinical trial — an announcement that was accompanied by presidential approval.

In a press release, TR Processing said that Clinton “followed the study through the Clinton Foundation.”

The former president said the study is an important part of efforts to reduce opioid dependence and addiction in the United States. TR Processing, citing data from the Centers for Disease Control and Prevention, noted that “more than 100,000 Americans died from drug overdoses in 2021 and a million lives have been lost from drug overdoses over the past two decades,” an “epidemic.” . [that] costs the US more than $1 trillion a year.”

“The Clinton Foundation has worked for years to reduce opioid addiction and deaths. To be successful, we need non-addictive alternatives to pain management,” Clinton said in a statement. “The results of the NYU Langone study of TRP’s CBD ingredient are very encouraging and I look forward to the next round of results.”

Michael J. Alaia, associate professor at NYU’s Department of Orthopedic Surgery and lead investigator on the study, said that “there is an urgent need for viable alternatives for pain management, and our study presents this form of CBD as a promising post-arthroscopy tool.” Rotator cuff repair.”

“It could be a new, low-cost approach to pain relief without the side effects of anti-inflammatory drugs like NSAIDs and the risks of addiction associated with opiates. Additionally, CBD has the benefit of pain relief without the psychotropic effects associated with THC or marijuana,” Alaia said.

Chris Kanaley, chief strategy officer at TR Processing, said the company is “committed to supporting the research and responsible commercialization of isolated cannabinoids, including CBD.”

“Tackling opioid abuse and addiction through the development of safer pain management alternatives is the first of many potential applications of our unique processing platform, and we are excited about the future. Our work has tremendous potential to become the best in precision medicine,” Kanaley said.